澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

CHIMERIC THERAPEUTICS LTD

0.006

0.000

成交量：- -

成交額：- -

市值：57.54萬

市盈率：-0.01

高：0.006

開：0.006

低：0.006

收：0.006

52周最高：0.400

52周最低：0.006

股本：9,590.64萬

流通股本：2,907.08萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.610

每股收益(LYR):-0.610

淨資產收益率：-1290.99%

總資產收益率：-46.75%

市淨率：-0.07

市盈率(LYR):-0.01

資料載入中...

總覽公司新聞資訊公告

體內通路取得進展，Chimeric Therapeutics擬與潛在合作伙伴重啓談判

Chimeric Therapeutics啓動戰略評估，或出售、授權或合作其CHM CDH17資產與項目

Chimeric Therapeutics Ltd實施重大成本削減措施，預計年度支出將減少約400萬澳元

Chimeric Therapeutics Ltd：FY26財務報告預計將包含持續經營重大不確定性

Chimeric Therapeutics 停牌：CDH17臨床試驗結果公布在即

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/CHM.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"CHM.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CHM.AU\",,,,,undefined,":{"symbol":"CHM.AU","market":"AU","secType":"STK","nameCN":"CHIMERIC THERAPEUTICS LTD","latestPrice":0.006,"timestamp":1789604810858,"preClose":0.006,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"CHIMERIC THERAPEUTICS LTD","floatShares":29070766,"shares":95906400,"eps":-0.6097,"marketStatus":"交易中","change":0,"latestTime":"09-17 10:52:05 AEST","open":0.006,"high":0.006,"low":0.006,"amount":0,"amplitude":0,"askPrice":0.007,"askSize":574163,"bidPrice":0.006,"bidSize":2627447,"shortable":3,"etf":0,"ttmEps":-0.6097,"tradingStatus":2,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789624800000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.006,"openAndCloseTimeList":[[1789603200000,1789624800000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CHM.AU","preClose":0.006,"auctionPrice":0.006,"auctionVolume":430000,"auction":3,"marketStatus":"盘后竞价","timestamp":1789539004932}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CHM.AU\",,,,,undefined,":{"symbol":"CHM.AU","floatShares":29070766,"roa":"-46.75%","roe":"-1290.99%","lyrEps":-0.6097,"shares":95906400,"dividePrice":0,"high":0.006,"amplitude":0,"preClose":0.006,"low":0.006,"week52Low":0.006,"pbRate":"-0.07","psRate":"-3.03","week52High":0.4,"institutionHeld":0,"latestPrice":0.006,"committee":0.641329,"eps":-0.6097,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.6097,"open":0.006,"prevYearClose":0.2,"prevWeekClose":0.008,"prevMonthClose":0.011,"prevQuarterClose":0.065,"fiveDayClose":0.008,"twentyDayClose":0.018,"sixtyDayClose":0.064,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CHM.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2026-04-22","symbol":"CHM.AU","defaultRemindTime":1776816000000,"type":"split","dateTimestamp":1776780000000,"forFactor":100,"toFactor":1,"ratio":100}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CHM.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CHM.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1133213709","title":"體內通路取得進展，Chimeric Therapeutics擬與潛在合作伙伴重啓談判","url":"https://stock-news.laohu8.com/highlight/detail?id=1133213709","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133213709?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 07:11","pubTimestamp":1787094670,"startTime":"0","endTime":"0","summary":"Chimeric Therapeutics Ltd——随着其体内通路不断推进，公司计划重新与潜在合作伙伴展开接触。\n这一动向标志着该生物制药企业在研发管线的关键节点上，正积极寻求外部协作与资源整合，以加速候选疗法的临床转化进程。\n在体内研究数据渐趋成熟的背景下，管理层显然认为，此刻正是重返谈判桌、深化战略联盟的恰当时机。无论是联合开发、授权许可，抑或是更广泛的商业合作，均有可能成为下一步棋局中的选项。\n市场观察人士指出，此类举措往往折射出企业对自身技术平台的信心增强，同时也暗示着其商业化路径正从实验室迈向更广阔的产业舞台。对于关注细胞治疗领域的投资者而言，这一信号无疑值得密切留意。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHM.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191148680","title":"Chimeric Therapeutics啓動戰略評估，或出售、授權或合作其CHM CDH17資產與項目","url":"https://stock-news.laohu8.com/highlight/detail?id=1191148680","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191148680?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 07:11","pubTimestamp":1787094668,"startTime":"0","endTime":"0","summary":"Chimeric Therapeutics（澳交所代码：CHM）宣布，已启动一项流程，旨在探索出售、对外许可或合作其CHM CDH17资产及相关项目的潜在可能。此举意味着公司正积极评估该资产在市场上的多种发展路径，以最大化其价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","CHM.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106385827","title":"Chimeric Therapeutics Ltd實施重大成本削減措施，預計年度支出將減少約400萬澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1106385827","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106385827?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 07:10","pubTimestamp":1787094609,"startTime":"0","endTime":"0","summary":"Chimeric Therapeutics Ltd——重大成本削减计划已正式落地，此举预计将使公司年度化支出缩减大约400万澳元。\n这家生物医药企业正积极调整运营策略，以优化财务结构。通过一系列精简措施，公司力求在维持核心研发管线推进的同时，显著降低整体资金消耗速率。\n此番成本控制动作，不仅反映了管理层对当前市场环境的审慎态度，也彰显了其提升资本效率、延长现金流跑道以支撑后续关键里程碑的决心。业界普遍认为，此类战略性节流举措，对于处于临床阶段、亟需平衡研发投入与财务稳健的生物科技公司而言，至关重要。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","CHM.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121509471","title":"Chimeric Therapeutics Ltd：FY26財務報告預計將包含持續經營重大不確定性","url":"https://stock-news.laohu8.com/highlight/detail?id=1121509471","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121509471?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 07:10","pubTimestamp":1787094609,"startTime":"0","endTime":"0","summary":"Chimeric Therapeutics Ltd（CHIMERIC THERAPEUTICS LTD）发布公告称，其2026财年财务报告预计将涵盖一项与持续经营相关的重大不确定性。这一消息揭示了公司在未来运营持续性方面可能面临的严峻挑战。根据公告内容，该不确定性因素的存在，可能对公司维持正常业务运作的能力构成实质性影响。投资者需密切关注这一动态，以评估公司未来的财务稳健性及可持续经营前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","CHM.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127776234","title":"Chimeric Therapeutics 停牌：CDH17臨床試驗結果公布在即","url":"https://stock-news.laohu8.com/highlight/detail?id=1127776234","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127776234?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 07:55","pubTimestamp":1786924508,"startTime":"0","endTime":"0","summary":"Chimeric Therapeutics（股票代码：CHM.AU）宣布其证券已进入停牌状态。此次停牌，旨在等待一项关于CDH17临床试验结果的公告发布。市场正屏息以待，这份公告将为投资者揭示关键的试验数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","CHM.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}]}}